STON2_HUMAN - dbPTM
STON2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID STON2_HUMAN
UniProt AC Q8WXE9
Protein Name Stonin-2
Gene Name STON2
Organism Homo sapiens (Human).
Sequence Length 905
Subcellular Localization Cytoplasm . Membrane . Cell junction, synapse, synaptosome. Some fraction is membrane-associated.
Protein Description Adapter protein involved in endocytic machinery. Involved in the synaptic vesicle recycling. May facilitate clathrin-coated vesicle uncoating..
Protein Sequence MTTLDHVIATHQSEWVSFNEEPPFPAHSQGGTEEHLPGLSSSPDQSESSSGENHVVDGGSQDHSHSEQDDSSEKMGLISEAASPPGSPEQPPPDLASAISNWVQFEDDTPWASTSPPHQETAETALPLTMPCWTCPSFDSLGRCPLTSESSWTTHSEDTSSPSFGCSYTDLQLINAEEQTSGQASGADSTDNSSSLQEDEEVEMEAISWQASSPAMNGHPAPPVTSARFPSWVTFDDNEVSCPLPPVTSPLKPNTPPSASVIPDVPYNSMGSFKKRDRPKSTLMNFSKVQKLDISSLNRTPSVTEASPWRATNPFLNETLQDVQPSPINPFSAFFEEQERRSQNSSISSTTGKSQRDSLIVIYQDAISFDDSSKTQSHSDAVEKLKQLQIDDPDHFGSATLPDDDPVAWIELDAHPPGSARSQPRDGWPMMLRIPEKKNIMSSRHWGPIFVKLTDTGYLQLYYEQGLEKPFREFKLEICHEISEPRLQNYDENGRIHSLRIDRVTYKEKKKYQPKPAVAHTAEREQVIKLGTTNYDDFLSFIHAVQDRLMDLPVLSMDLSTVGLNYLEEEITVDVRDEFSGIVSKGDNQILQHHVLTRIHILSFLSGLAECRLGLNDILVKGNEIVLRQDIMPTTTTKWIKLHECRFHGCVDEDVFHNSRVILFNPLDACRFELMRFRTVFAEKTLPFTLRTATSVNGAEVEVQSWLRMSTGFSANRDPLTQVPCENVMIRYPVPSEWVKNFRRESVLGEKSLKAKVNRGASFGSTSVSGSEPVMRVTLGTAKYEHAFNSIVWRINRLPDKNSASGHPHCFFCHLELGSDREVPSRFANHVNVEFSMPTTSASKASVRSISVEDKTDVRKWVNYSAHYSYQVALGSIWLMLPTPFVHPTTLPLLFLLAMLTMFAW
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
168PhosphorylationSPSFGCSYTDLQLIN
CCCCCCCHHEEEEEC
14.3522817900
231PhosphorylationVTSARFPSWVTFDDN
CCCCCCCCCEEECCC
31.31-
234PhosphorylationARFPSWVTFDDNEVS
CCCCCCEEECCCEEC
18.32-
241PhosphorylationTFDDNEVSCPLPPVT
EECCCEECCCCCCCC
12.1127251275
248PhosphorylationSCPLPPVTSPLKPNT
CCCCCCCCCCCCCCC
30.3327251275
249PhosphorylationCPLPPVTSPLKPNTP
CCCCCCCCCCCCCCC
28.5924719451
255PhosphorylationTSPLKPNTPPSASVI
CCCCCCCCCCCCCCC
45.1427251275
267PhosphorylationSVIPDVPYNSMGSFK
CCCCCCCCCCCCCCC
21.5125627689
269PhosphorylationIPDVPYNSMGSFKKR
CCCCCCCCCCCCCCC
20.7625627689
272PhosphorylationVPYNSMGSFKKRDRP
CCCCCCCCCCCCCCC
25.8325159151
281PhosphorylationKKRDRPKSTLMNFSK
CCCCCCCCCCCCHHH
29.4730266825
282PhosphorylationKRDRPKSTLMNFSKV
CCCCCCCCCCCHHHC
35.8330266825
287PhosphorylationKSTLMNFSKVQKLDI
CCCCCCHHHCEECCH
27.2330266825
295PhosphorylationKVQKLDISSLNRTPS
HCEECCHHHCCCCCC
28.5630266825
296PhosphorylationVQKLDISSLNRTPSV
CEECCHHHCCCCCCC
29.9625849741
300PhosphorylationDISSLNRTPSVTEAS
CHHHCCCCCCCCCCC
20.8825159151
302PhosphorylationSSLNRTPSVTEASPW
HHCCCCCCCCCCCCC
40.8525159151
304PhosphorylationLNRTPSVTEASPWRA
CCCCCCCCCCCCCCC
30.1223186163
307PhosphorylationTPSVTEASPWRATNP
CCCCCCCCCCCCCCC
20.8225159151
319PhosphorylationTNPFLNETLQDVQPS
CCCCCCCCCCCCCCC
28.7527251275
326PhosphorylationTLQDVQPSPINPFSA
CCCCCCCCCCCCCHH
22.7125159151
342PhosphorylationFEEQERRSQNSSISS
HHHHHHHHCCCCCCC
39.6825627689
345PhosphorylationQERRSQNSSISSTTG
HHHHHCCCCCCCCCC
22.7825262027
346PhosphorylationERRSQNSSISSTTGK
HHHHCCCCCCCCCCC
33.7625262027
348PhosphorylationRSQNSSISSTTGKSQ
HHCCCCCCCCCCCCH
24.4725262027
349PhosphorylationSQNSSISSTTGKSQR
HCCCCCCCCCCCCHH
28.4625262027
350PhosphorylationQNSSISSTTGKSQRD
CCCCCCCCCCCCHHC
32.5525262027
351PhosphorylationNSSISSTTGKSQRDS
CCCCCCCCCCCHHCE
44.5625262027
353UbiquitinationSISSTTGKSQRDSLI
CCCCCCCCCHHCEEE
41.12-
354PhosphorylationISSTTGKSQRDSLIV
CCCCCCCCHHCEEEE
31.6228857561
358PhosphorylationTGKSQRDSLIVIYQD
CCCCHHCEEEEEEEE
23.3728857561
363PhosphorylationRDSLIVIYQDAISFD
HCEEEEEEEEECCCC
6.8828060719
368PhosphorylationVIYQDAISFDDSSKT
EEEEEECCCCCCCCC
25.0928060719
384UbiquitinationSHSDAVEKLKQLQID
CCHHHHHHHHHCCCC
55.152190698
384 (in isoform 1)Ubiquitination-55.1521906983
386UbiquitinationSDAVEKLKQLQIDDP
HHHHHHHHHCCCCCC
61.09-
437AcetylationMMLRIPEKKNIMSSR
EEEECCCCCCCCCCC
45.8518604539
498PhosphorylationDENGRIHSLRIDRVT
CCCCCEEEEEEEEEE
19.5724719451
512PhosphorylationTYKEKKKYQPKPAVA
EHHCCCCCCCCCCCC
38.6422210691
515UbiquitinationEKKKYQPKPAVAHTA
CCCCCCCCCCCCCHH
30.04-
580PhosphorylationVDVRDEFSGIVSKGD
EEEHHHHCCEEECCC
26.0922617229
621UbiquitinationGLNDILVKGNEIVLR
CCCCEEEECCEEEEC
53.20-
638UbiquitinationIMPTTTTKWIKLHEC
CCCCCCCCEEEEEEC
44.84-
684UbiquitinationFRTVFAEKTLPFTLR
HHHEECCCCCCEEEE
52.51-
684AcetylationFRTVFAEKTLPFTLR
HHHEECCCCCCEEEE
52.5126051181
689PhosphorylationAEKTLPFTLRTATSV
CCCCCCEEEEECCCC
17.2524719451
746PhosphorylationVKNFRRESVLGEKSL
HHHCHHHHHCCCHHH
22.3423312004
751UbiquitinationRESVLGEKSLKAKVN
HHHHCCCHHHHHHCC
60.33-
762PhosphorylationAKVNRGASFGSTSVS
HHCCCCCCCCCCCCC
32.7225159151
765PhosphorylationNRGASFGSTSVSGSE
CCCCCCCCCCCCCCC
18.5928857561
766PhosphorylationRGASFGSTSVSGSEP
CCCCCCCCCCCCCCC
33.2628857561
767PhosphorylationGASFGSTSVSGSEPV
CCCCCCCCCCCCCCE
18.9128857561
769PhosphorylationSFGSTSVSGSEPVMR
CCCCCCCCCCCCEEE
36.0526434776
771PhosphorylationGSTSVSGSEPVMRVT
CCCCCCCCCCEEEEE
31.0826434776
856PhosphorylationSISVEDKTDVRKWVN
EEECCCCCCHHHHHH
52.64-
914 (in isoform 3)Phosphorylation-27251275
915 (in isoform 3)Phosphorylation-27251275
918 (in isoform 3)Phosphorylation-27251275

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of STON2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of STON2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of STON2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
EP15R_HUMANEPS15L1physical
11381094
EPS15_HUMANEPS15physical
11381094
ITSN1_HUMANITSN1physical
11381094
SYT2_HUMANSYT2physical
11381094
SYT1_HUMANSYT1physical
11381094
SYT1_HUMANSYT1physical
11454741
AP2M1_HUMANAP2M1physical
11454741
CSN4_HUMANCOPS4physical
21102408
EPS15_HUMANEPS15physical
18200045

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of STON2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-300 AND SER-302, ANDMASS SPECTROMETRY.

TOP